Syndax Pharma (SNDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2014 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -24,119 | -19,828 | N/A | N/A |
| Depreciation Amortization | 1,086 | 101 | N/A | N/A |
| Accounts payable and accrued liabilities | 1,045 | -726 | N/A | N/A |
| Other Working Capital | 14,560 | 551 | N/A | N/A |
| Other Operating Activity | 5,000 | 5,509 | 0 | 0 |
| Operating Cash Flow | $-2,428 | $-14,393 | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| Change In Deposits | -61,502 | 1,893 | N/A | N/A |
| PPE Investments | -49 | -4 | N/A | N/A |
| Other Investing Activity | -118 | -1 | 0 | 0 |
| Investing Cash Flow | $-61,669 | $1,888 | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Debt Issued | N/A | 14,000 | N/A | N/A |
| Debt Repayment | -9,000 | N/A | N/A | N/A |
| Common Stock Issued | 191 | 6 | N/A | N/A |
| Other Financing Activity | 86,076 | -1,596 | 0 | 0 |
| Financing Cash Flow | $77,267 | $12,410 | $N/A | $N/A |
| Beginning Cash Position | 10,009 | 10,104 | N/A | N/A |
| End Cash Position | 23,179 | 10,009 | N/A | N/A |
| Net Cash Flow | $13,170 | $-95 | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -2,428 | -14,393 | N/A | N/A |
| Capital Expenditure | -49 | -4 | N/A | N/A |
| Free Cash Flow | -2,477 | -14,397 | 0 | 0 |